Various alphabetized medical records

Life Sciences Government & Regulatory Investigations

Our Life Sciences team leverages its deep industry knowledge and familiarity with health-care data analytics to help our clients navigate government and regulatory investigations involving civil, criminal, and regulatory enforcement issues. We have expertise in pharmaceutical pricing and reimbursement and the intersection of these areas with government regulations. Our team has experience working with complex data, including Medicare, Medicaid, and private insurance claims data, pharmaceutical sales data, and market research to investigate questions of wrongful conduct, causation and damages. Our experts also serve as monitors during post-merger activities.


  • 01
    CRA addresses U.S. government healthcare programs and pharmaceutical pricing in False Claims Act suit
    In this whistleblower suit, a relator alleged Bristol-Myers Squibb Co. (“BMS”) violated the False Claims Act and various state claims. The suit alleged that...
    View engagement
  • 02
    CRA assesses distributor practices for controlled substances
    CRA was retained by distributors of pharmaceutical products in national litigation relating to opioid products. CRA addressed claims by state and local...
    View engagement
  • 03
    CRA evaluates Canadian pharmaceutical pricing
    CRA provided expert testimony in multiple proceedings before the Patented Medicine Prices Review Board (PMPRB) in relation to alleged excessive pricing by...
    View engagement

Subscribe to receive our latest Insights.